Detalhe da pesquisa
1.
Filling a nick in NIK: Extending the half-life of a NIK inhibitor through structure-based drug design.
Bioorg Med Chem Lett
; 89: 129277, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37105490
2.
Computational analysis of kinase inhibitor selectivity using structural knowledge.
Bioinformatics
; 35(2): 235-242, 2019 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29985971
3.
Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: a new treatment strategy for ibrutinib-resistant CLL.
Blood
; 132(10): 1039-1049, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30018078
4.
Bruton's Tyrosine Kinase Small Molecule Inhibitors Induce a Distinct Pancreatic Toxicity in Rats.
J Pharmacol Exp Ther
; 360(1): 226-238, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821712
5.
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
Nature
; 471(7336): 110-4, 2011 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21368834
6.
Structure of the pseudokinase-kinase domains from protein kinase TYK2 reveals a mechanism for Janus kinase (JAK) autoinhibition.
Proc Natl Acad Sci U S A
; 111(22): 8025-30, 2014 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24843152
7.
Discovery of oxa-sultams as RORc inverse agonists showing reduced lipophilicity, improved selectivity and favorable ADME properties.
Bioorg Med Chem Lett
; 26(18): 4455-4461, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27524313
8.
Discovery of highly potent and selective Bruton's tyrosine kinase inhibitors: Pyridazinone analogs with improved metabolic stability.
Bioorg Med Chem Lett
; 26(2): 575-579, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26675441
9.
Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonists.
Bioorg Med Chem Lett
; 25(19): 4109-13, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26321361
10.
Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists.
Bioorg Med Chem Lett
; 25(15): 2907-12, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26048793
11.
A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitors.
J Immunol
; 191(5): 2205-16, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23894201
12.
Image processing for cameras with fiber bundle image relay.
Appl Opt
; 54(5): 1124-37, 2015 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25968031
13.
Panoramic monocentric imaging using fiber-coupled focal planes.
Opt Express
; 22(26): 31708-21, 2014 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25607140
14.
Identification of tertiary sulfonamides as RORc inverse agonists.
Bioorg Med Chem Lett
; 24(9): 2182-7, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24685544
15.
Reduction in lipophilicity improved the solubility, plasma-protein binding, and permeability of tertiary sulfonamide RORc inverse agonists.
Bioorg Med Chem Lett
; 24(16): 3891-7, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25017032
16.
A reversed sulfonamide series of selective RORc inverse agonists.
Bioorg Med Chem Lett
; 24(24): 5769-5776, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25453817
17.
Discovery of TRPA1 Antagonist GDC-6599: Derisking Preclinical Toxicity and Aldehyde Oxidase Metabolism with a Potential First-in-Class Therapy for Respiratory Disease.
J Med Chem
; 67(5): 3287-3306, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38431835
18.
Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc.
Bioorg Med Chem Lett
; 23(24): 6604-9, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24239186
19.
Crystal structure of bis(3,5-dichloro-2-hydroxybenzyl)(2-methoxyethyl)amine.
Acta Crystallogr E Crystallogr Commun
; 79(Pt 9): 782-785, 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37693661
20.
Selective MMP13 inhibitors.
Med Res Rev
; 31(6): 863-94, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20196103